U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
| Name | Lori Wolfe Teva Pharmaceuticals USA, Inc. |
|---|---|
| Address | 400 Interpace Parkway Parsippany, NJ 07054 United States |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Aug-17-2023 | NEW APPLICATION ENTERED | NWAPI | |
| Sep-12-2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Mar-04-2024 | ASSIGNED TO EXAMINER | DOCKD | |
| Mar-12-2024 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
| Mar-27-2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
| Apr-16-2024 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Apr-16-2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
| Jun-11-2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
| Nov-21-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| Nov-21-2024 | SOU EXTENSION 1 FILED | EXT1S | |
| Nov-21-2024 | SOU EXTENSION 1 GRANTED | EX1GS | |
| Nov-21-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| May-28-2025 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| May-28-2025 | SOU EXTENSION 2 FILED | EXT2S | |
| May-28-2025 | SOU EXTENSION 2 GRANTED | EX2GS | |
| Sep-15-2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| Jan-12-2026 | ABANDONMENT - NO USE STATEMENT FILED | ABN6S | |
| Jan-12-2026 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | MAB6E | |
| Jan-21-2026 | TEAS CHANGE OF OWNER ADDRESS RECEIVED | COARI | |
| Jan-21-2026 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | CHANI | |
| Jan-21-2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Jan-21-2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Jan-21-2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | TCCAI |